NeoGenomics to Participate in Upcoming June Investor Conferences

Audio By Carbonatix

FORT MYERS, Fla.--(BUSINESS WIRE)--May 20, 2025--

NeoGenomics, Inc. (“NeoGenomics” or the “Company”) (NASDAQ:NEO), a leading oncology testing services company, today announced the Company will participate in the following investor conferences:

• William Blair 45th Annual Growth Stock Conference in Chicago, IL
  Company presentation on Tuesday, June 3, at 1:00 pm ET, accessible here
• Jefferies Global Healthcare Conference in New York, NY
  Fireside chat on Wednesday, June 4, at 2:00 pm ET, accessible here

Live and archived webcasts of the sessions may be viewed on the Investor Relations section of the Company’s website at ir.neogenomics.com.

About NeoGenomics

NeoGenomics, Inc. is a premier cancer diagnostics company specializing in cancer genetics testing and information services. We offer one of the most comprehensive oncology-focused testing menus across the cancer continuum, serving oncologists, pathologists, hospital systems, academic centers, and pharmaceutical firms with innovative diagnostic and predictive testing to help them diagnose and treat cancer. Headquartered in Fort Myers, FL, NeoGenomics operates a network of CAP-accredited and CLIA-certified laboratories for full-service sample processing and analysis services throughout the US and a CAP-accredited full-service sample-processing laboratory in Cambridge, United Kingdom.

View source version on businesswire.com:https://www.businesswire.com/news/home/20250520247873/en/

CONTACT: Investor Contact

Kendra Sweeney

[email protected] Contact

Andrea Sampson

[email protected]

KEYWORD: UNITED STATES NORTH AMERICA ILLINOIS NEW YORK FLORIDA

INDUSTRY KEYWORD: ONCOLOGY HEALTH MEDICAL DEVICES HOSPITALS GENETICS RADIOLOGY BIOTECHNOLOGY

SOURCE: NeoGenomics, Inc.

Copyright Business Wire 2025.

PUB: 05/20/2025 07:05 AM/DISC: 05/20/2025 07:05 AM

http://www.businesswire.com/news/home/20250520247873/en